Chemical Name: (S)-N-(4-Chloro-2-(4-cyclopropyl-1,1,1-trifluoro-2-hydroxybut-3-yn-2-yl)phenyl)-4-methoxybenzamide
Smiles: O=C(NC1=CC=C(Cl)C=C1[C@](C#CC2CC2)(O)C(F)(F)F)C3=CC=C(OC)C=C3
Inchi: InChI=1S/C22H17ClF3NO3/c1-29-17-7-4-15(5-8-17)13-27-19-9-6-16(23)12-18(19)21(22(24,25)26,30-20(27)28)11-10-14-2-3-14/h4-9,12,14H,2-3,13H2,1H3/t21-/m0/s1
Development and validation of a HPLC analytical assay method for efavirenz tablets: a medicine for HIV infections
Osnir de Sá Viana1 , Flávia Patrícia Morais Medeiros2 , Severino Grangeiro-Júnior2 , Miracy Muniz Albuquerque1 , Mônica Felts La Roca Soares1-3, José Lamartine Soares-Sobrinho1-3, Lariza Darlene Santos Alves1 , Larissa Araújo Rolim1 , Keyla Emanuelle Ramos da Silva1 , Pedro José Rolim-Neto
Braz. J. Pharm. Sci. vol.47 no.1 São Paulo Jan./Mar. 2011
Investigation of the solvent-dependent photolysis of a nonnucleoside reverse-transcriptase inhibitor, antiviral agent efavirenz
Maryam A Jordaan and Michael Shapi
Antiviral Chemistry and Chemotherapy 2017: 1–11
Method Development and Validation for Related Impurities of Efavirenz by RP-HPLC Method
Desaraju Bhargavi, Bhukya Babu Rao, Gangarapu Kiran, Thumma Gouthami & Vasudha Bakshi
TACL 7 (5) 2017 pp 737 – 747